Patents by Inventor George Peter Lomonossoff
George Peter Lomonossoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210155947Abstract: The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.Type: ApplicationFiled: September 9, 2020Publication date: May 27, 2021Inventors: Frank Sainsbury, George Peter Lomonossoff
-
Patent number: 10947549Abstract: The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.Type: GrantFiled: August 31, 2020Date of Patent: March 16, 2021Assignee: PLANT BIOSCIENCE LIMITEDInventors: Frank Sainsbury, George Peter Lomonossoff
-
Publication number: 20200392522Abstract: The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.Type: ApplicationFiled: August 31, 2020Publication date: December 17, 2020Inventors: Frank Sainsbury, George Peter Lomonossoff
-
Patent number: 10822613Abstract: The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.Type: GrantFiled: August 11, 2017Date of Patent: November 3, 2020Assignee: PLANT BIOSCIENCE LIMITEDInventors: Frank Sainsbury, George Peter Lomonossoff
-
Publication number: 20180030462Abstract: The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.Type: ApplicationFiled: August 11, 2017Publication date: February 1, 2018Inventors: Frank Sainsbury, George Peter Lomonossoff
-
Publication number: 20140250549Abstract: The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.Type: ApplicationFiled: February 4, 2014Publication date: September 4, 2014Applicant: PLANT BIOSCIENCE LIMITEDInventors: Frank Sainsbury, George Peter Lomonossoff
-
Patent number: 8674084Abstract: The inventions is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (‘CPMV-HT’) based protein expression system.Type: GrantFiled: January 8, 2009Date of Patent: March 18, 2014Assignee: Plant Bioscience LimitedInventors: Frank Sainsbury, George Peter Lomonossoff
-
Publication number: 20120284871Abstract: Disclosed herein are methods and materials, and particularly viral derived sequences, for boosting gene expression in plants and other eukaryotic cells. The methods and materials may be used for boosting expression of heterologous genes encoding proteins of interest.Type: ApplicationFiled: May 4, 2012Publication date: November 8, 2012Applicant: PLANT BIOSCIENCE LIMITEDInventors: George Peter Lomonossoff, Pooja Saxena, Yulia Alexandrovna Meshcheriakova
-
Publication number: 20120174263Abstract: The invention provides methods of producing “empty” RNA virus capsids (e.g. from Cowpea mosaic virus) by assembly of viral small (S) and large (L) coat proteins in such a way that encapsidation of native viral RNA is avoided. Aspects of the invention employ in planta expression of capsid components from DNA vectors encoding the S and L proteins or S-L polyproteins including them. Such capsids have utility for the encapsidation or presentation of foreign proteins or desired payloads.Type: ApplicationFiled: June 15, 2010Publication date: July 5, 2012Applicant: PLANT BIOSCIENCE LIMITEDInventors: Keith Saunders, George Peter Lomonossoff, Frank Sainsbury
-
Publication number: 20100287670Abstract: The inventions is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (‘CPMV-HT’) based protein expression system.Type: ApplicationFiled: January 8, 2009Publication date: November 11, 2010Inventors: Frank Sainsbury, George Peter Lomonossoff
-
Patent number: 7208655Abstract: The invention relates to assembled particles of a plant virus containing a predetermined foreign peptide as part of the coat protein of the virus, and a method for their production. The foreign peptide is preferably a biologically functional peptide, the biological application of which requires or is enhanced by presentation of the peptide in association with a larger molecule or particle.Type: GrantFiled: May 30, 2000Date of Patent: April 24, 2007Assignee: The Dow Chemical CompanyInventors: George Peter Lomonossoff, John Emil Johnson
-
Patent number: 6110466Abstract: The invention relates to assembled particles of a plant virus containing a predetermined foreign peptide as part of the coat protein of the virus, and a method for their production. The foreign peptide is preferably a biologically functional peptide, the biological application of which requires or is enhanced by presentation of the peptide in association with a larger molecule or particle.Type: GrantFiled: December 15, 1993Date of Patent: August 29, 2000Assignees: Axis Genetics PLC, Purdue Research FoundationInventors: George Peter Lomonossoff, John Emil Johnson
-
Patent number: 5958422Abstract: The invention relates to assembled particles of a plant virus containing a foreign peptide insert in the coat protein of the virus. The site of the insert is free from direct sequence repeats flanking the insert. The invention also relates to a method of production of the particles and their use, in particular in vaccines.Type: GrantFiled: June 5, 1996Date of Patent: September 28, 1999Assignee: Axis Genetics PLCInventor: George Peter Lomonossoff
-
Patent number: 5874087Abstract: The invention relates to assembled particles of a plant virus containing a predetermined foreign peptide as part of the coat protein of the virus, and a method for their production. The foreign peptide is preferably a biologically functional peptide, the biological application of which requires or is enhanced by presentation of the peptide in association with a larger molecule or particle.Type: GrantFiled: June 6, 1995Date of Patent: February 23, 1999Assignees: Axis Genetics PLC, Purdue Research FoundationInventors: George Peter Lomonossoff, John Emil Johnson